Jang, B.-K.; Shin, S.J.; Park, H.H.; Kumar, V.; Park, Y.H.; Kim, J.-Y.; Kang, H.-Y.; Park, S.; Kwon, Y.; Shin, S.-E.;
et al. Investigation of Novel Aronia Bioactive Fraction-Alginic Acid Nanocomplex on the Enhanced Modulation of Neuroinflammation and Inhibition of Aβ Aggregation. Pharmaceutics 2025, 17, 13.
https://doi.org/10.3390/pharmaceutics17010013
AMA Style
Jang B-K, Shin SJ, Park HH, Kumar V, Park YH, Kim J-Y, Kang H-Y, Park S, Kwon Y, Shin S-E,
et al. Investigation of Novel Aronia Bioactive Fraction-Alginic Acid Nanocomplex on the Enhanced Modulation of Neuroinflammation and Inhibition of Aβ Aggregation. Pharmaceutics. 2025; 17(1):13.
https://doi.org/10.3390/pharmaceutics17010013
Chicago/Turabian Style
Jang, Bong-Keun, Soo Jung Shin, Hyun Ha Park, Vijay Kumar, Yong Ho Park, Jeom-Yong Kim, Hye-Yeon Kang, Sunyoung Park, Youngsun Kwon, Sang-Eun Shin,
and et al. 2025. "Investigation of Novel Aronia Bioactive Fraction-Alginic Acid Nanocomplex on the Enhanced Modulation of Neuroinflammation and Inhibition of Aβ Aggregation" Pharmaceutics 17, no. 1: 13.
https://doi.org/10.3390/pharmaceutics17010013
APA Style
Jang, B.-K., Shin, S. J., Park, H. H., Kumar, V., Park, Y. H., Kim, J.-Y., Kang, H.-Y., Park, S., Kwon, Y., Shin, S.-E., Moon, M., & Lee, B.-J.
(2025). Investigation of Novel Aronia Bioactive Fraction-Alginic Acid Nanocomplex on the Enhanced Modulation of Neuroinflammation and Inhibition of Aβ Aggregation. Pharmaceutics, 17(1), 13.
https://doi.org/10.3390/pharmaceutics17010013
